Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:67-73

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andriambeloson, E.
Right arrow Articles by Hans-Günter Zerwes,
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andriambeloson, E.
Right arrow Articles by Hans-Günter Zerwes,
Related Collections
Right arrow Animal models of human disease
Right arrow Other arteriosclerosis
Right arrow Transplantation
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:67.)
© 2001 American Heart Association, Inc.


Vascular Biology

Endothelial Dysfunction and Denudation in Rat Aortic Allografts

Emile Andriambeloson; Marc Bigaud; Edo O. Schraa; Tanja Kobel; Valerie Lobstein; Charles Pally; Hans-Günter Zerwes

From Novartis Pharma AG, Transplantation Research, Basel, Switzerland.

Correspondence to Hans-Günter Zerwes, PhD, Novartis Pharma AG, Transplantation Research, WSJ-386.5.26, CH 4002 Basel, Switzerland. E-mail Hans-Guenter.Zerwes{at}pharma.novartis.com

Abstract—Clinical evidence suggests that early endothelial cell (EC) dysfunction may predict the development of graft vascular disease. We wished to assess the early functional and morphological changes in the graft endothelium in a commonly used animal model of graft vascular disease, the rat aortic interposition allograft model. To assess graft EC function, regulation of vascular tone by ECs was monitored in aortic rings from grafts harvested at various times after transplantation (Tx). EC morphology was assessed by silver staining, which was followed by en face inspection of the luminal side of the grafts. Acetylcholine-induced EC-dependent vasorelaxation was reduced in allografts at post-Tx days 7 and 14, whereas in syngeneic grafts EC-dependent relaxation was unaffected at any time after Tx. In separate grafts collected at the same time points, massive leukocyte adhesion at post-Tx day 7 and EC denudation at days 14 and 28 were evident in allografts but not in syngeneic grafts. At post-Tx day 56 (a time at which vessel wall remodeling is pronounced in this model), an intact EC layer covered the grafts. EC dysfunction and morphological changes were prevented by immunosuppression of recipient rats with cyclosporine. Our study shows that Tx-induced EC dysfunction in rat aortic allografts can be observed within 1 week of Tx in rat aortic allografts and that this is occurring concomitantly with enhanced leukocyte adhesion to the graft ECs. These changes occur before any other morphological or functional changes described thus far in this model and appear to be immune-driven. Taken together, these results show that Tx-induced early EC dysfunction, as described in patients, may be studied in the model of rat aortic Tx.


Key Words: endothelium • vasorelaxation • graft • rejection • aorta